Respiratory syncytial virus is common but it can be dangerous for some infants and young kids. Here's everything parents need ...

Merck's Enflonsia vaccine for respiratory syncytial virus won approval from the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices.

The eight new ACIP members met for the first time June 25 after Kennedy fired all 17 original members of the committee June 9 ...

A CDC advisory panel on Thursday voted 5-2 to recommend the use of a new preventative RSV therapy in babies, Merck’s Enflonsia.

Robert F. Kennedy Jr. had fired all 17 members of a key vaccine panel. Now his new panel recommended a new infant RSV vaccine. What to know.

The CDC currently recommends RSV vaccines for adults 75 and older, plus those 60-74 at increased risk. The final CDC recommendation remains pending for the expanded age group before availability.

The vote offers a sigh of relief to doctors and public health experts worried about vaccine skepticism creeping into policymaking.

Merck's Enflonsia vaccine for respiratory syncytial virus won approval from the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices.

According to the CDC, RSV infects nearly everyone by age 2, causing cold symptoms, and sometimes, breathing struggles. In the U.S., around 300 infant deaths are caused by RSV each year.

RSV is causing thousands of infant deaths in India yearly, yet remains underdiagnosed. Experts stress the urgent need for ...

In recent weeks, Health and Human Services Secretary Robert F. Kennedy Jr. has begun to dismantle decades of vaccine safety ...

Follow the latest RSV cases news stories and headlines. Get breaking news alerts when you download the ABC News App and subscribe to RSV cases notifications.